IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 28, 2008, Pages 9733-9738

  Luedde, Tom ^a,b,d   Heinrichsdorff, Jan ^a   De Lorenzi, Rossana ^b   De Vos, Rita ^c   Roskams, Tania ^c   Pasparakis, Manolis ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cholangitis; Inflammation; Liver disease; Mouse models; Signal transduction

Indexed keywords

CYTOKINE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; BILE DUCT DISEASE; BILIARY TRACT DISEASE; CHOLANGITIS; CONTROLLED STUDY; ENZYME ACTIVITY; HOMEOSTASIS; JAUNDICE; LIVER; LIVER CELL; LIVER FAILURE; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BILE DUCT DISEASES; BILE DUCTS; HEPATOCYTES; I-KAPPA B KINASE; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, KNOCKOUT; NF-KAPPA B;

MUS;

EID: 47749136267     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0800198105     Document Type: Article

References (34)

1. Nakanuma Y, Tsuneyama K, Harada K (2001) Pathology and pathogenesis of intrahepatic bile duct loss. J Hepatobiliary Pancreat Surg 8:303-315.
2. O'Leary JG, Pratt DS (2007) Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol 23:232-236.
3. Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261-1273.
4. Bonizzi G, Karin M (2004) The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280-288.
5. Hayden MS, Ghosh S (2004) Signaling to NF-κB. Genes Dev 18:2195-2224.
6. Perkins ND (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 8:49-62.
7. Li Q, Verma IM (2002) NF-κB regulation in the immune system. Nat Rev Immunol 2:725-734.
8. Luedde T, et al. (2007) Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11:119-132.
9. Maeda S, Kamata H, Luo JL, Leffert H, Karin M (2005) IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121:977-990.
10. Pikarsky E, et al. (2004) NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461-466.
11. Gareus R, et al. (2007) Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat Cell Biol 9:461-469.
12. Pasparakis M, et al. (2002) TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417:861-866.
13. Schmidt-Supprian M, et al. (2000) NEMO/IKKγ-deficient mice model incontinentia pigmenti. Mol Cell 5:981-992.
14. Kellendonk C, Opherk C, Anlag K, Schutz G, Tronche F (2000) Hepatocyte-specific expression of Cre recombinase. Genesis 26:151-153.
15. Coffinier C, et al. (2002) Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1β. Development 129:1829-1838.
16. Maeda S, et al. (2003) IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19:725-737.
17. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM (1999) Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284:321-325.
18. Tanaka M, et al. (1999) Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10:421-429.
19. Li Q, Estepa G, Memet S, Israel A, Verma IM (2000) Complete lack of NF-κB activity in IKK1 and IKK2 double-deficient mice: Additional defect in neurulation. Genes Dev 14:1729-1733.
20. Chen LF, Greene WC (2004) Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 5:392-401.
21. Kojima T, et al. (2003) Regulation of the blood-biliary barrier: Interaction between gap and tight junctions in hepatocytes. Med Electron Microsc 36:157-164.
22. Yamamoto T, et al. (2004) IL-1β regulates expression of cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways. Exp Cell Res 299:427-441.
23. Hadj-Rabia S, et al. (2004) Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: A tight junction disease. Gastroenterology 127:1386-1390.
24. Mack CL, Sokol RJ (2005) Unraveling the pathogenesis and etiology of biliary atresia. Pediatr Res 57:87R-94R.
25. Hanada S, et al. (2003) Tumor necrosis factor-α and interferon-γ directly impair epithelial barrier function in cultured mouse cholangiocytes. Liver Int 23:3-11.
26. Miyoshi H, Rust C, Guicciardi ME, Gores GJ (2001) NF-κB is activated in cholestasis and functions to reduce liver injury. Am J Pathol 158:967-975.
27. Cao Y, Luo JL, Karin M (2007) IκB kinase α kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. Proc Natl Acad Sci USA 104:15852-15857.
28. Huang WC, Ju TK, Hung MC, Chen CC (2007) Phosphorylation of CBP by IKKα promotes cell growth by switching the binding preference of CBP from p53 to NF-κB. Mol Cell 26:75-87.
29. Connelly L, et al. (2007) A transgenic model reveals important roles for the NF-κB alternative pathway (p100/p52) in mammary development and links to tumorigenesis. J Biol Chem 282:10028-10035.
30. Schumm K, Rocha S, Caamano J, Perkins ND (2006) Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunit. EMBO J 25:4820-4832.
31. Demicco EG, et al. (2005) Relb/p52 NF-κB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IκB-α expression and promote carcinogenesis of the mammary gland. Mol Cell Biol 25:10136-10147.
32. Akhurst B, et al. (2005) Differential lymphotoxin-β and interferon-γ signaling during mouse liver regeneration induced by chronic and acute injury. Hepatology 41:327-335.
33. Lee JS, et al. (2006) A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 12:410-416.
34. Beuers U, Rust C (2005) Overlap syndromes. Semin Liver Dis 25:311-320.